ghk-cu antibody formation neutralizing antibodies Antiviral antibodies: from in vitro to in vivo activity Copper tripeptide (GHK-Cu) | Tripeptide

Imagine waking up refreshed, tingling gone, moving freely, and feeling energized

H57.9 vs

A 50mg vial is consumed across a shorter working life, which means fewer stopper penetrations, less cumulative light exposure and fewer freeze-thaw cycles on one reconstituted stock

Originally developed through groundbreaking research at Erasmus University Medical Center, FOXO4-DRI represents a targeted approach to cellular rejuvenation and has shown remarkable promise in preclinical studies for promoting healthspan and addressing age-related cellular dysfunction

FDA.gov (2026) 10

DSIP does not have the same level of clinical evidence or regulatory clarity for insomnia treatment